PPLPHARMAPiramal Pharma Limited
Convert to ideaPharmaceuticals & Biotechnology · Pharmaceuticals
The verdict combines business quality, price and timing. Sign in free to see it.
Sign in freeUp 2.0 this quarter.
Momentum from moving averages, Supertrend and RSI.
2 forensic issues found. Sign in to see which.
Valuation Metrics
Q2 FY2027Intrinsic value, Graham number and DCF against today's price
2 found · risk elevated
Quality, growth, balance sheet and earnings quality behind the score
ⓘ Based on fundamental & forensic analysis. Always verify against official filings and consult a financial advisor.
Financial Metrics
Comparing Q2 FY2027 vs Q2 FY2026
| Quarter | Revenue | Net Profit | OPM | NPM | EPS | Int. Cover |
|---|---|---|---|---|---|---|
| Q2 FY2027 | ₹2617 Cr | ₹5 Cr | 4.42% | 0.19% | ₹0.04 | 1.7x |
| Q1 FY2027 | ₹2270 Cr | ₹-69 Cr | -1.25% | -3.06% | ₹-0.52 | 0.7x |
| Q4 FY2026 | ₹2752 Cr | ₹-9 Cr | 8.80% | -0.32% | ₹-0.07 | 1.4x |
| Q3 FY2026 | ₹2140 Cr | ₹-136 Cr | -0.79% | -6.36% | ₹-1.03 | -0.2x |
| Q2 FY2026 | ₹2044 Cr | ₹-99 Cr | -2.16% | -4.85% | ₹-0.75 | 0.3x |
| Q1 FY2026 | ₹1934 Cr | ₹-82 Cr | -4.68% | -4.23% | ₹-0.62 | -0.1x |
Momentum score, 1-year chart, moving averages, support and resistance.
Turnaround stage, and how each measure moved over 3 years against the company's own range.
Order wins, capex, pledges, rating actions and every material filing.
Management guidance, Q&A highlights and whether they delivered what they said.
The earnings call read across investor dimensions.
Promoter, FII and mutual fund holding, and what changed this quarter.
Similar-size peers in Pharmaceuticals
Compare with peers →Piramal Pharma Limited operates as a pharmaceutical company in the United States, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities and distribution network. It also operates contract development and manufacturing organization that provides services across the drug life cycle, including discovery, development, and commercial manufacturing of drug substances and products; offers inhalation anesthetics, intrathecal therapy, injectable pain and anesthesia drugs, and other generic and specialty products; and analgesics, skin care, vitamin/mineral supplement, kids' wellness, digestives, women's health, and hygiene, as well as adult incontinence. The company was incorporated in 2020 and is based in Mumbai, India.
Note: This comprehensive analysis combines technical data, fundamental data, and investment thesis. Always do your own research and consider your personal risk tolerance before investing.